Skin Laboratory PCL (BKK:SKIN)
Thailand flag Thailand · Delayed Price · Currency is THB
0.8900
-0.0200 (-2.20%)
At close: Aug 10, 2026

Skin Laboratory PCL Financials Overview

Millions THB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
167.08178.96230.53272.8282.7198.57
Revenue Growth
-22.82%-22.37%-15.49%-3.50%42.37%17.80%
Gross Profit
119.71129.43173.03209.56212.05133.02
Operating Income
-7.25.7413.5321.2815.1936.59
Net Income
-7.794.3810.6716.7911.8628.77
Earnings Per Share
-0.060.040.258.395.9314.39
EPS Growth
--84.35%-97.04%41.59%-58.80%-

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
71.4577.7729.7849.5537.9744.8
Total Debt
1.121.452.684.453.542.67
Net Cash (Debt)
70.3376.3327.145.0934.4342.13
Net Cash Growth
159.55%181.68%-39.91%30.98%-18.28%-7.00%
Net Cash Per Share
0.570.680.6322.5517.2121.06

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.3212.464.6126.554.7611.22
Capital Expenditures
-0.49-0.49-1.04-0.31-0.15-0.35
Free Cash Flow
-6.8111.973.5726.254.6210.87
Free Cash Flow Growth
-235.34%-86.40%468.69%-57.53%25.74%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
71.65%72.32%75.06%76.82%75.01%66.98%
Operating Margin
-4.31%3.21%5.87%7.80%5.37%18.42%
Pretax Margin
-4.39%3.12%5.87%7.71%5.31%18.34%
Profit Margin
-4.66%2.45%4.63%6.15%4.19%14.49%
FCF Margin
-4.08%6.69%1.55%9.62%1.63%5.47%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-44.41----
P/FCF Ratio
-16.24----
PS Ratio
0.771.09----